Camlin Fine Sciences (CAMLINFINE)₹78.53+1.34%Specialty Chemicals
At the end of the Jun 2026 quarter, Camlin Fine Sciences' shareholders were: promoters 48.00%, FIIs 0.92%, DIIs 5.47%, public 45.61%. Promoter holding is unchanged on the quarter. FII holding is down 1.98 percentage points from 2.90% a year earlier. It had 55,167 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 48.00% | 48.00% | 48.01% | 48.00% | 48.00% | 48.00% | 49.06% | 49.06% | 49.05% | 48.00% | 48.00% | 48.00% |
| FIIs | 1.62% | 1.00% | 1.70% | 1.02% | 0.82% | 0.77% | 1.48% | 2.90% | 2.13% | 2.14% | 0.95% | 0.92% |
| DIIs | 3.93% | 3.79% | 4.59% | 4.93% | 4.27% | 3.41% | 3.87% | 4.18% | 5.53% | 7.83% | 7.76% | 5.47% |
| Public | 46.45% | 47.22% | 45.70% | 46.05% | 46.91% | 47.82% | 45.59% | 43.86% | 43.29% | 42.03% | 43.29% | 45.61% |
| Number of shareholders | 57,086 | 62,085 | 58,153 | 62,674 | 67,736 | 61,880 | 58,099 | 59,526 | 57,649 | 52,346 | 52,221 | 55,167 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Ashish Subhash Dandekar | Promoter | 10.28% | 0.00 |
| Infinity Direct Holdings | Promoter | 10.13% | 0.00 |
| Anfima Nv | Promoter | 8.79% | 0.00 |
| Infinity Holdings | Promoter | 6.19% | 0.00 |
| Infinity Direct Capital | Promoter | 4.81% | 0.00 |
| Icici Prudential Commodities Fund | DII | 4.74% | −0.03 |
| Camart Finance Limited | Promoter | 2.74% | 0.00 |
| Nirmal Vinod Momaya | Public | 1.86% | 0.00 |
| Anagha Subhash Dandekar | Promoter | 1.58% | 0.00 |
| Vibha Agencies Pvt Ltd | Promoter | 1.37% | 0.00 |
| Ajay Upadhyaya | Public | 1.29% | 0.00 |
| Infinity Portfolio Holdings | Promoter | 1.16% | 0.00 |
| Jagdish N Master | Public | 1.02% | +0.01 |
| Cafco Consultants Limited | Promoter | 0.77% | 0.00 |
| Radha Pandit | Promoter | 0.04% | 0.00 |
| Anand Y Pandit | Promoter | 0.01% | 0.00 |
| Franklin India Opportunites Fund | DII | Exited | — |
Promoters held 48.00% of Camlin Fine Sciences at the end of the Jun 2026 quarter, down 1.06 percentage points from 49.06% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.92% (down 0.03 percentage points from 0.95% a quarter earlier) and domestic institutions (DIIs) held 5.47% (down 2.29 percentage points from 7.76% a quarter earlier).
Camlin Fine Sciences had 55,167 shareholders at the end of the Jun 2026 quarter, against 59,526 a year earlier.
Icici Prudential Commodities Fund (DII) held 4.74% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.